These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3929504)

  • 1. [The genus Pseudomonas: new aspects of an old problem].
    Kalina GP
    Zh Mikrobiol Epidemiol Immunobiol; 1985 May; (5):91-8. PubMed ID: 3929504
    [No Abstract]   [Full Text] [Related]  

  • 2. Pseudomonas aeruginosa OxyR is required for full virulence in rodent and insect models of infection and for resistance to human neutrophils.
    Lau GW; Britigan BE; Hassett DJ
    Infect Immun; 2005 Apr; 73(4):2550-3. PubMed ID: 15784603
    [No Abstract]   [Full Text] [Related]  

  • 3. Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: extracellular protease and elastase as in vivo virulence factors.
    Holder IA; Haidaris CG
    Can J Microbiol; 1979 May; 25(5):593-9. PubMed ID: 89891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of motility and flagellin glycosylation in the pathogenesis of Pseudomonas aeruginosa burn wound infections.
    Arora SK; Neely AN; Blair B; Lory S; Ramphal R
    Infect Immun; 2005 Jul; 73(7):4395-8. PubMed ID: 15972536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Protease activity of strains of Pseudomonas aeruginosa isolated from different sources].
    Brodinova NS; Luchina TIa; Adzhieva AA; Moroz AF
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Oct; (10):54-7. PubMed ID: 6800163
    [No Abstract]   [Full Text] [Related]  

  • 6. Pseudomonas aeruginosa infection: pathogenesis and therapy.
    Pennington JE
    Compr Ther; 1979 May; 5(5):14-22. PubMed ID: 110508
    [No Abstract]   [Full Text] [Related]  

  • 7. Observations on Pseudomonas aeruginosa proteolytic and toxic activity in experimentally infected rats.
    Ogaard AR; Lausund P; Berdal BP
    NIPH Ann; 1992 Dec; 15(2):99-109. PubMed ID: 1480313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology and pathogenesis of Pseudomonas aeruginosa infections.
    Moore NM; Flaws ML
    Clin Lab Sci; 2011; 24(1):43-6. PubMed ID: 21404964
    [No Abstract]   [Full Text] [Related]  

  • 9. Pseudomonas aeruginosa virulence and antimicrobial resistance: two sides of the same coin?
    Hauser AR
    Crit Care Med; 2014 Jan; 42(1):201-2. PubMed ID: 24346525
    [No Abstract]   [Full Text] [Related]  

  • 10. [Survival of Pseudomonas aeruginosa in the hospital environment].
    Vlodavets VV; Trukhina GM; Aĭzen MS; Moĭseenko NN; Svistunova TS
    Gig Sanit; 1986 Oct; (10):22-5. PubMed ID: 3098631
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antibiotic sensitivity and pathogenetic factors of hospital strains of Pseudomonas aeruginosa isolated from patients treated in a resuscitation unit].
    Gabisoniia TG; Makaridze MR; Chanishvili TG; Iashvili BP
    Antibiot Khimioter; 1992 Feb; 37(2):17-8. PubMed ID: 1387518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pseudomonad infection in human pathology].
    Iliukhin VI
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Feb; (2):110-4. PubMed ID: 3922180
    [No Abstract]   [Full Text] [Related]  

  • 13. Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: immunization using divalent flagella preparations.
    Holder IA; Naglich JG
    J Trauma; 1986 Feb; 26(2):118-22. PubMed ID: 2418208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics, isolation and role in the infectious process of Pseudomonas aeruginosa protease.
    Brodinova NS; Moroz AF; Luchina TYa
    J Hyg Epidemiol Microbiol Immunol; 1983; 27(1):69-76. PubMed ID: 6406591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of clinical isolates of Pseudomonas aeruginosa. I. Resistance to serum bactericidal effect and production of proteolytic enzymes.
    Pajdak E; Szkarłat A; Kobylarz K
    Arch Immunol Ther Exp (Warsz); 1990; 38(3-4):309-14. PubMed ID: 2129385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental infection with Pseudomonas aeruginosa in mice. I. The virulence of Pseudomonas aeruginosa for mice.
    Kobayashi F
    Jpn J Microbiol; 1971 Jul; 15(4):295-300. PubMed ID: 4330067
    [No Abstract]   [Full Text] [Related]  

  • 17. Quantitation of Pseudomonas aeruginosa in wound biopsy samples: from bacterial culture to rapid 'real-time' polymerase chain reaction.
    Pirnay JP; De Vos D; Duinslaeger L; Reper P; Vandenvelde C; Cornelis P; Vanderkelen A
    Crit Care; 2000; 4(4):255-61. PubMed ID: 11056755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular enzymes of fecal strains of Pseudomonas aeruginosa.
    Marne C; Vindel A
    Eur J Clin Microbiol Infect Dis; 1988 Apr; 7(2):307-9. PubMed ID: 2839341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of silver ion resistance to the pathogenicity of Pseudomonas aeruginosa with special reference to burn wound sepsis.
    Vasishta R; Saxena M; Chhibber S
    Folia Microbiol (Praha); 1991; 36(5):498-501. PubMed ID: 1821876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudomonas keratitis: protease IV gene conservation, distribution, and production relative to virulence and other Pseudomonas proteases.
    Caballero A; Thibodeaux B; Marquart M; Traidej M; O'Callaghan R
    Invest Ophthalmol Vis Sci; 2004 Feb; 45(2):522-30. PubMed ID: 14744894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.